Skip to main content Skip to section navigation Skip to footer
IR-Med, Inc.
  • How it Works
  • Indications
    • Pressure Injury
    • Pediatric Ear Infections
    • Drug-Level Monitoring
    • Cinical Research
  • Investors
  • About Us
    • Overview
    • Our Team
  • PressureSafe
  • Contact us
Menu
  • How it Works
  • Indications
    • Pressure Injury
    • Pediatric Ear Infections
    • Drug-Level Monitoring
    • Cinical Research
  • Investors
  • About Us
    • Overview
    • Our Team
  • PressureSafe
  • Contact us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
Dec 21, 2023 9:15 AM EST

IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine

Dec 07, 2023 9:15 AM EST

IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue

Oct 04, 2023 4:05 PM EDT

IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer

Sep 26, 2023 9:00 AM EDT

IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024

Sep 13, 2023 9:15 AM EDT

IR-MED Appoints Richard Serbin, Esq. to its Advisory Board

Aug 21, 2023 9:15 AM EDT

IR-MED Chairman & Interim CEO Issues Letter to Shareholders

Jul 17, 2023 9:15 AM EDT

IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care

Jun 12, 2023 9:15 AM EDT

IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries

Jun 07, 2023 9:28 AM EDT

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

May 19, 2023 9:15 AM EDT

IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed

MENU

  • Home
  • How it Works
  • Indications
  • Investors
  • About Us

Contact us

  • +972-4-6555054
  • contact@ir-medical.com
  • Z.H.R Industrial Zone, P.O. Box 143, 20 Yahalom St. Rosh Pinna, 1231400, ISRAEL

Social media

Twitter Linkedin

©2025 IR-Med, Inc., PressureSafe and Nobotics are trademarks of IR-MEd, Inc. All rights reserved.